CMS’s Big Drug Price Reveal Turns Out Better For Pharma Than Feared
The first round of US government drug price negotiations resulted in prices for 10 drugs that will lower aggregate net spending by 22%
The first round of US government drug price negotiations resulted in prices for 10 drugs that will lower aggregate net spending by 22%